MAPK3 and cancer: In addition, the impact on the phosphorylation levels of ERK1/2 after E-cadherin expression further support that, in this cancer cell model, the IR/IGF-IR-mediated downstream pathway that is preferentially activated is the Ras/Raf/MEK/ERK.